Highlights
KLSE: DPHARMA (7148)       DUOPHARMA BIOTECH BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
1.52   -0.06 (3.80%)  1.51 - 1.57  2,168,000
Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.

Financials


Market Cap: 1,040 Million

Market Cap 1,040 Million
NOSH 684 Million

Latest Audited Result:  31-Dec-2018

Latest Audited Result: 31-Dec-2018
Announcement Date 29-Apr-2019
Next Audited Result: 31-Dec-2019
Est. Ann. Date: 29-Apr-2020
Est. Ann. Due Date: 28-Jun-2020

Latest Quarter:  31-Dec-2019 [#4]

Latest Quarter: 31-Dec-2019 [#4]
Announcement Date 13-Feb-2020
Next Quarter: 31-Mar-2020
Est. Ann. Date: 21-May-2020
Est. Ann. Due Date: 30-May-2020
QoQ | YoY   -19.02%  |    -16.26%

Annual (Unaudited) ( EPS: 8.08, P/E: 18.82 )

Revenue | NP to SH 576,462  |  55,273
RPS | P/RPS 84.23 Cent  |  1.80
EPS | P/E | EY 8.08 Cent  |  18.82  |  5.31%
DPS | DY | Payout % 5.98 Cent  |  3.93%  |  74.06%
NAPS | P/NAPS 0.77  |  1.98
YoY   16.02%
NP Margin | ROE 9.59%  |  10.52%
F.Y. | Ann. Date 31-Dec-2019  |  13-Feb-2020

T4Q Result ( EPS: 8.08, P/E: 18.82 )

Revenue | NP to SH 576,462  |  55,273
RPS | P/RPS 84.23 Cent  |  1.80
EPS | P/E | EY 8.08 Cent  |  18.82  |  5.31%
DPS | DY | Payout % 5.95 Cent  |  3.91%  |  73.69%
NAPS | P/NAPS 0.77  |  1.98
QoQ | YoY   -4.05%  |    15.69%
NP Margin | ROE 9.59%  |  10.52%
F.Y. | Ann. Date 31-Dec-2019  |  13-Feb-2020

Annualized Result ( EPS: 8.08, P/E: 18.82 )

Revenue | NP to SH 576,462  |  55,273
RPS | P/RPS 84.23 Cent  |  1.80
EPS | P/E | EY 8.08 Cent  |  18.82  |  5.31%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -4.13%  |    16.02%
NP Margin | ROE 9.59%  |  10.52%
F.Y. | Ann. Date 31-Dec-2019  |  13-Feb-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2019 13-Feb-2020 31-Dec-2019 4 137,755 13,939 12,033 12,033 34,114 525,364 283.51% 8.74% 2.29% 682,292 20.19 20.13 1.76 1.76 5.00 4.98 0.7700 0.77   -19.02%   -16.26% 31-Dec-2019 1.42 7.03 80.52 1.84 1.24% 3.52% 13-Feb-2020 1.64 8.12 92.99 2.13 1.08% 3.05%
31-Dec-2019 29-Nov-2019 30-Sep-2019 3 142,855 19,768 14,859 14,859 - 505,919 - % 10.40% 2.94% 674,559 21.18 20.87 2.20 2.17 0.00 0.00 0.7500 0.74   6.78%   20.94% 30-Sep-2019 1.40 6.61 63.56 1.87 1.57% 0.00% 29-Nov-2019 1.39 6.56 63.10 1.85 1.58% 0.00%
31-Dec-2019 30-Aug-2019 30-Jun-2019 2 145,466 18,316 13,916 13,916 6,618 503,029 47.56% 9.57% 2.77% 661,881 21.98 21.26 2.07 2.03 1.00 0.97 0.7600 0.74   -3.80%   34.60% 28-Jun-2019 1.37 6.23 65.16 1.80 1.53% 0.73% 30-Aug-2019 1.41 6.42 67.06 1.86 1.49% 0.71%
31-Dec-2019 21-May-2019 31-Mar-2019 1 150,386 18,786 14,465 14,465 - 496,410 - % 9.62% 2.91% 661,881 22.72 21.97 2.19 2.11 0.00 0.00 0.7500 0.73   0.67%   34.16% 29-Mar-2019 1.28 5.63 58.57 1.71 1.71% 0.00% 21-May-2019 1.36 5.99 62.23 1.81 1.61% 0.00%
31-Dec-2018 18-Feb-2019 31-Dec-2018 4 115,634 17,658 14,369 14,369 26,475 483,173 184.25% 12.43% 2.97% 661,881 17.47 16.90 2.17 2.10 4.00 3.87 0.7300 0.71   16.95%   21.05% 31-Dec-2018 0.95 5.44 43.76 1.30 2.29% 4.21% 18-Feb-2019 1.03 5.90 47.45 1.41 2.11% 3.88%
31-Dec-2018 28-Nov-2018 30-Sep-2018 3 125,838 15,838 12,286 12,286 - 501,487 - % 9.76% 2.45% 659,852 19.07 18.39 1.86 1.80 0.00 0.00 0.7600 0.73   18.83%   7.72% 28-Sep-2018 1.23 6.45 66.06 1.62 1.51% 0.00% 28-Nov-2018 1.07 5.61 57.47 1.41 1.74% 0.00%
31-Dec-2018 26-Nov-2018 30-Jun-2018 2 123,991 12,915 10,339 10,339 4,199 209,983 40.62% 8.34% 4.92% 279,978 44.29 18.12 1.59 1.51 1.50 0.61 0.7500 0.31   -4.11%   7.11% 29-Jun-2018 1.30 2.94 35.20 1.73 2.84% 1.15% 26-Nov-2018 1.08 2.44 29.25 1.44 3.42% 1.39%
31-Dec-2018 28-May-2018 31-Mar-2018 1 133,259 13,255 10,647 10,782 - 206,429 - % 7.99% 5.22% 278,959 47.77 19.47 3.82 1.58 0.00 0.00 0.7400 0.30   -9.17%   25.11% 30-Mar-2018 2.80 5.86 72.44 3.78 1.38% 0.00% 28-May-2018 3.35 7.01 86.67 4.53 1.15% 0.00%
31-Dec-2017 28-Feb-2018 31-Dec-2017 4 112,253 12,825 11,768 11,870 16,737 479,809 141.01% 10.48% 2.47% 278,959 40.24 16.40 4.22 1.73 6.00 2.45 1.7200 0.70   4.08%   40.84% 29-Dec-2017 2.53 6.29 59.46 1.47 1.68% 2.37% 28-Feb-2018 2.97 7.38 69.80 1.73 1.43% 2.02%
31-Dec-2017 17-Nov-2017 30-Sep-2017 3 115,379 14,207 11,127 11,405 - 474,230 - % 9.64% 2.40% 278,959 41.36 16.86 3.99 1.67 0.00 0.00 1.7000 0.69   18.15%   79.86% 29-Sep-2017 2.20 5.32 53.81 1.29 1.86% 0.00% 17-Nov-2017 2.20 5.32 53.81 1.29 1.86% 0.00%
31-Dec-2017 25-Aug-2017 30-Jun-2017 2 117,049 12,642 9,641 9,653 6,973 463,071 72.25% 8.24% 2.08% 278,959 41.96 17.10 3.46 1.41 2.50 1.02 1.6600 0.68   12.01%   114.37% 30-Jun-2017 2.25 5.36 65.02 1.36 1.54% 1.11% 25-Aug-2017 2.03 4.84 58.66 1.22 1.70% 1.23%
31-Dec-2017 22-May-2017 31-Mar-2017 1 120,994 11,176 8,618 8,618 - 463,071 - % 7.12% 1.86% 278,959 43.37 17.68 3.43 1.26 0.00 0.00 1.6600 0.68   2.25%   9.88% 31-Mar-2017 2.31 5.33 74.77 1.39 1.34% 0.00% 22-May-2017 2.32 5.35 75.10 1.40 1.33% 0.00%
31-Dec-2016 24-Feb-2017 31-Dec-2016 4 74,033 6,299 8,831 8,428 11,158 454,703 132.40% 11.93% 1.85% 278,959 26.54 10.82 3.41 1.23 4.00 1.63 1.6300 0.66   32.91%   -45.04% 30-Dec-2016 1.98 7.46 65.54 1.21 1.53% 2.02% 24-Feb-2017 2.23 8.40 73.81 1.37 1.35% 1.79%
31-Dec-2016 21-Nov-2016 30-Sep-2016 3 80,302 7,516 6,226 6,341 - 451,913 - % 7.75% 1.40% 278,959 28.79 11.73 2.23 0.93 0.00 0.00 1.6200 0.66   40.82%   -26.46% 30-Sep-2016 2.06 7.16 90.63 1.27 1.10% 0.00% 21-Nov-2016 2.10 7.30 92.39 1.30 1.08% 0.00%
31-Dec-2016 22-Aug-2016 30-Jun-2016 2 79,135 7,723 3,941 4,503 6,973 446,334 154.87% 4.98% 1.01% 278,959 28.37 11.56 1.41 0.66 2.50 1.02 1.6000 0.65   -42.59%   -23.00% 30-Jun-2016 2.04 7.19 126.38 1.28 0.79% 1.23% 22-Aug-2016 2.14 7.54 132.57 1.34 0.75% 1.17%
31-Dec-2016 18-May-2016 31-Mar-2016 1 79,470 9,941 7,828 7,843 - 457,492 - % 9.85% 1.71% 278,959 28.49 11.61 2.81 1.15 0.00 0.00 1.6400 0.67   -48.86%   -12.55% 31-Mar-2016 2.55 8.95 90.70 1.55 1.10% 0.00% 18-May-2016 2.40 8.42 85.36 1.46 1.17% 0.00%
31-Dec-2015 23-Feb-2016 31-Dec-2015 4 89,401 17,529 17,529 15,335 9,172 270,177 59.82% 19.61% 5.68% 166,776 53.61 13.06 9.19 2.24 5.50 1.34 1.6200 0.39   77.84%   37.92% 31-Dec-2015 2.62 4.89 28.49 1.62 3.51% 2.10% 23-Feb-2016 2.61 4.87 28.39 1.61 3.52% 2.11%
31-Dec-2015 24-Nov-2015 30-Sep-2015 3 79,372 11,621 8,623 8,623 - 268,509 - % 10.86% 3.21% 166,776 47.59 11.60 5.17 1.26 0.00 0.00 1.6100 0.39   47.45%   -0.68% 30-Sep-2015 2.72 5.72 52.61 1.69 1.90% 0.00% 24-Nov-2015 2.70 5.67 52.22 1.68 1.91% 0.00%
31-Dec-2015 25-Aug-2015 30-Jun-2015 2 56,308 8,407 5,848 5,848 5,582 189,815 95.47% 10.39% 3.08% 139,570 40.34 8.23 4.19 0.85 4.00 0.82 1.3600 0.28   -34.80%   -22.16% 30-Jun-2015 2.65 6.57 63.25 1.95 1.58% 1.51% 25-Aug-2015 2.40 5.95 57.28 1.76 1.75% 1.67%
31-Dec-2015 18-May-2015 31-Mar-2015 1 45,599 12,198 8,969 8,969 - 205,045 - % 19.67% 4.37% 139,486 32.69 6.66 6.43 1.31 0.00 0.00 1.4700 0.30   -19.34%   7.22% 31-Mar-2015 3.88 11.87 60.34 2.64 1.66% 0.00% 18-May-2015 3.90 11.93 60.65 2.65 1.65% 0.00%
31-Dec-2014 24-Feb-2015 31-Dec-2014 4 51,024 13,921 13,921 11,119 20,128 192,951 181.02% 27.28% 5.76% 138,813 36.76 7.46 8.01 1.62 14.50 2.94 1.3900 0.28   28.07%   19.39% 31-Dec-2014 2.50 6.80 31.21 1.80 3.20% 5.80% 24-Feb-2015 2.92 7.94 36.45 2.10 2.74% 4.97%
31-Dec-2014 21-Nov-2014 30-Sep-2014 3 44,819 11,287 8,682 8,682 - 187,531 - % 19.37% 4.63% 138,912 32.26 6.55 6.25 1.27 0.00 0.00 1.3500 0.27   15.56%   27.94% 30-Sep-2014 3.17 9.83 50.72 2.35 1.97% 0.00% 21-Nov-2014 3.01 9.33 48.16 2.23 2.08% 0.00%
31-Dec-2014 26-Aug-2014 30-Jun-2014 2 40,623 10,107 7,513 7,513 5,554 179,145 73.94% 18.49% 4.19% 138,872 29.25 5.94 5.41 1.10 4.00 0.81 1.2900 0.26   -10.19%   -29.71% 30-Jun-2014 2.97 10.15 54.90 2.30 1.82% 1.35% 26-Aug-2014 3.37 11.52 62.29 2.61 1.61% 1.19%
31-Dec-2014 20-May-2014 31-Mar-2014 1 40,495 11,175 8,365 8,365 - 190,050 - % 20.66% 4.40% 138,723 29.19 5.92 6.03 1.22 0.00 0.00 1.3700 0.28   -10.18%   24.87% 31-Mar-2014 3.03 10.38 50.25 2.21 1.99% 0.00% 20-May-2014 3.09 10.59 51.24 2.26 1.95% 0.00%
31-Dec-2013 26-Feb-2014 31-Dec-2013 4 45,734 9,160 9,313 9,313 18,737 181,818 201.19% 20.36% 5.12% 138,792 32.95 6.68 6.71 1.36 13.50 2.74 1.3100 0.27   37.24%   55.27% 31-Dec-2013 2.58 7.83 38.45 1.97 2.60% 5.23% 26-Feb-2014 2.60 7.89 38.75 1.98 2.58% 5.19%
31-Dec-2013 19-Nov-2013 30-Sep-2013 3 40,845 9,054 6,786 6,786 - 179,017 - % 16.61% 3.79% 138,773 29.43 5.97 4.89 0.99 0.00 0.00 1.2900 0.26   -36.51%   5.34% 30-Sep-2013 2.55 8.66 52.15 1.98 1.92% 0.00% 19-Nov-2013 2.56 8.70 52.35 1.98 1.91% 0.00%
31-Dec-2013 28-Aug-2013 30-Jun-2013 2 37,988 13,007 10,689 10,689 5,552 187,404 51.95% 28.14% 5.70% 138,818 27.37 5.55 7.70 1.56 4.00 0.81 1.3500 0.27   59.56%   55.66% 28-Jun-2013 2.38 8.70 30.91 1.76 3.24% 1.68% 28-Aug-2013 2.44 8.92 31.69 1.81 3.16% 1.64%
31-Dec-2013 27-May-2013 31-Mar-2013 1 37,837 8,956 6,699 6,699 - 176,143 - % 17.70% 3.80% 138,695 27.28 5.53 4.83 0.98 0.00 0.00 1.2700 0.26   11.69%   -0.13% 29-Mar-2013 2.23 8.17 46.17 1.76 2.17% 0.00% 27-May-2013 2.51 9.20 51.97 1.98 1.92% 0.00%
31-Dec-2012 25-Feb-2013 31-Dec-2012 4 35,378 9,000 5,998 5,998 14,576 169,359 243.02% 16.95% 3.54% 138,819 25.48 5.17 4.32 0.88 10.50 2.13 1.2200 0.25   -6.89%   -5.23% 31-Dec-2012 2.13 8.36 49.30 1.75 2.03% 4.93% 25-Feb-2013 2.17 8.51 50.22 1.78 1.99% 4.84%
31-Dec-2012 23-Nov-2012 30-Sep-2012 3 29,521 8,391 6,442 6,442 - 167,991 - % 21.82% 3.83% 138,836 21.26 4.31 4.64 0.94 0.00 0.00 1.2100 0.25   -6.19%   -14.35% 28-Sep-2012 2.36 11.10 50.86 1.95 1.97% 0.00% 23-Nov-2012 2.28 10.72 49.14 1.88 2.04% 0.00%
31-Dec-2012 16-Aug-2012 30-Jun-2012 2 34,355 9,037 6,867 6,867 4,855 162,310 70.71% 19.99% 4.23% 138,727 24.76 5.02 4.95 1.00 3.50 0.71 1.1700 0.24   2.37%   -0.94% 29-Jun-2012 2.23 9.00 45.05 1.91 2.22% 1.57% 16-Aug-2012 2.38 9.61 48.08 2.03 2.08% 1.47%
31-Dec-2012 17-May-2012 31-Mar-2012 1 36,057 8,869 6,708 6,708 - 170,824 - % 18.60% 3.93% 138,881 25.96 5.27 4.83 0.98 0.00 0.00 1.2300 0.25   5.99%   13.23% 30-Mar-2012 2.40 9.24 49.69 1.95 2.01% 0.00% 17-May-2012 2.38 9.17 49.28 1.93 2.03% 0.00%
31-Dec-2011 22-Feb-2012 31-Dec-2011 4 33,036 7,836 6,329 6,329 20,125 163,776 317.98% 19.16% 3.86% 138,793 23.80 4.83 4.56 0.92 14.50 2.94 1.1800 0.24   -15.85%   -26.53% 30-Dec-2011 2.02 8.49 44.30 1.71 2.26% 7.18% 22-Feb-2012 2.12 8.91 46.49 1.80 2.15% 6.84%
31-Dec-2011 21-Nov-2011 30-Sep-2011 3 36,767 9,726 7,521 7,521 - 162,353 - % 20.46% 4.63% 138,763 26.50 5.37 5.42 1.10 0.00 0.00 1.1700 0.24   8.50%   -1.29% 30-Sep-2011 2.10 7.93 38.75 1.79 2.58% 0.00% 21-Nov-2011 2.10 7.93 38.75 1.79 2.58% 0.00%
31-Dec-2011 18-Aug-2011 30-Jun-2011 2 35,345 9,292 6,932 6,932 4,862 154,198 70.14% 19.61% 4.50% 138,917 25.44 5.16 4.99 1.01 3.50 0.71 1.1100 0.23   17.02%   -5.12% 30-Jun-2011 2.34 9.20 46.89 2.11 2.13% 1.50% 18-Aug-2011 2.22 8.73 44.49 2.00 2.25% 1.58%
31-Dec-2011 25-May-2011 31-Mar-2011 1 32,984 7,875 5,924 5,924 - 162,320 - % 17.96% 3.65% 138,735 23.77 4.82 4.27 0.87 0.00 0.00 1.1700 0.24   -31.23%   15.48% 31-Mar-2011 2.35 9.88 55.04 2.01 1.82% 0.00% 25-May-2011 2.57 10.81 60.19 2.20 1.66% 0.00%
31-Dec-2010 23-Feb-2011 31-Dec-2010 4 32,195 8,607 8,614 8,614 152 156,744 1.77% 26.76% 5.50% 138,711 23.21 4.70 6.21 1.26 0.11 0.02 1.1300 0.23   13.06%   9.82% 30-Dec-2010 2.39 10.30 38.49 2.12 2.60% 0.05% 23-Feb-2011 2.45 10.56 39.45 2.17 2.53% 0.04%
31-Dec-2010 26-Nov-2010 30-Sep-2010 3 34,464 10,221 7,619 7,619 - 148,494 - % 22.11% 5.13% 138,779 24.83 5.04 5.49 1.11 0.00 0.00 1.0700 0.22   4.28%   9.96% 30-Sep-2010 2.44 9.83 44.44 2.28 2.25% 0.00% 26-Nov-2010 2.38 9.58 43.35 2.22 2.31% 0.00%
31-Dec-2010 24-Aug-2010 30-Jun-2010 2 35,982 9,790 7,306 7,306 6,250 140,286 85.55% 20.30% 5.21% 138,897 25.91 5.26 5.26 1.07 4.50 0.91 1.0100 0.20   42.42%   -13.87% 30-Jun-2010 2.45 9.46 46.58 2.43 2.15% 1.84% 24-Aug-2010 2.45 9.46 46.58 2.43 2.15% 1.84%
31-Dec-2010 25-May-2010 31-Mar-2010 1 28,796 6,792 5,130 5,130 - 146,967 - % 17.81% 3.49% 138,648 20.77 4.21 3.70 0.75 0.00 0.00 1.0600 0.21   -34.60%   -26.48% 31-Mar-2010 2.40 11.56 64.86 2.26 1.54% 0.00% 25-May-2010 2.38 11.46 64.32 2.25 1.55% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  4 people like this.
 
rajachulan I had stopped buying any stock which dealing with gomen... many months ago... after i have seen how gomen play construction sector...

gdluck buying stock dealing with gomen...
11/09/2019 11:00 AM
kalofarmako “The big problem is price control, not Pharmaniaga,” says MyCC

Social activist Lim Mah Hui, one of the conductors of the MyCC study, said Pharmaniaga did not have a monopoly over supply but a virtual monopoly over logistics.

Check out: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224759.jsp
13/09/2019 9:52 AM
rajachulan no doubt... healthcare and insurance are two industries APAC to grow next few decade... however... if the govt !@#$%^&*()... then !@#$%^&*()
13/09/2019 10:07 AM
Jason drop like hell, this counter really need super long term investment
17/09/2019 2:01 PM
chshzhd buy..
17/09/2019 4:40 PM
Jason volume coming in this few days, many people is accumulating
18/09/2019 5:51 PM
Tan AB cominggg
20/09/2019 9:11 AM
Tan AB 10 sen. gg
20/09/2019 3:54 PM
Shootup will monitor 2molo, ready to buy
30/09/2019 8:31 PM
Jason consolidate for so long at around1.4
30/09/2019 10:06 PM
soccerking82 what is mean by Interim Dividend (with Dividend Re-Investment Plan) ?

It is by default go to dividend re-investment plan or we need to fill in some form ?

Actually i more prefer receive dividend, and i don't want have odd lot in my account.
03/10/2019 5:07 PM
kalofarmako The public need to understand that Pharmaniaga's role as a concessionaire and not immediately liken it to a monopoly. Shared some thoughts in this article (https://klse.i3investor.com/blogs/MYpharmaceuticalnews/228733.jsp). Though it could use a bit more context but hope this can get the conversation going.

Source: http://read.focusmalaysia.my/ePaper/xml_epaper/Focus/05_10_2019/pla_1_Standard/xml_arts/art_52429.htm
07/10/2019 4:23 PM
patrick2 any news on the renewal contract?
13/10/2019 10:36 AM
Shinnzaii wait MOH open tender only...Duopharma seem like got higher chance then Apexhealthcare since Duopharma under CCM...
31/10/2019 5:27 PM
factorrumour support local dpharma from pnb, itu apexhealth from singapura
31/10/2019 8:14 PM
Chewing Gum Super potential counter! All in!
02/11/2019 3:12 PM
kalofarmako Pharmaniaga's services would be extended until the Cabinet decides on the mechanism to manage the open tender.

source link: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234024.jsp
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234024.jsp
06/11/2019 2:57 PM
moneytrail No energy to break 1.45 after so long. Go hibernate first.
07/11/2019 4:30 AM
kalofarmako Pharmaniaga Bhd witnessed a 300% spike in orders, largely from hospitals and government clinics after the government announced the firm’s drugs and medical supply concession would end on Nov 30.

Check this out!!! https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234455.jsp
08/11/2019 10:52 AM
kalofarmako POSITIVE REACTION ON PHARMANIAGA EXTENSION

Sources Link:https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234829.jsp
11/11/2019 4:43 PM
kalofarmako Check this out!!!

Sources Link:https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234991.jsp
12/11/2019 11:13 AM
kalofarmako PHARMANIAGA STOCK RECORD YEAR’S STRONGEST JUMP

Check this out!!!

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/235081.jsp
12/11/2019 5:21 PM
kalofarmako Pharmaniaga Bhd confirms today that it has secured a five-year extension for the provision of logistics and distribution services to the Ministry of Health, to end on Dec 31, 2024.

Check this out:
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/237671.jsp
19/11/2019 11:40 AM
kalofarmako https://klse.i3investor.com/blogs/MYpharmaceuticalnews/238123.jsp

Govt extends Pharmaniaga services for medicines, medical supplies
20/11/2019 12:00 PM
factorrumour eh, why didn't promote pharmaniaga profit drop? that's why dont come here promote other share

HAHAHAHAHAHAHAHAHAHAHAHHAA


Posted by kalofarmako > Nov 20, 2019 12:00 PM | Report Abuse

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/238123.jsp

Govt extends Pharmaniaga services for medicines, medical supplies

Posted by kalofarmako > Nov 19, 2019 11:40 AM | Report Abuse

Pharmaniaga Bhd confirms today that it has secured a five-year extension for the provision of logistics and distribution services to the Ministry of Health, to end on Dec 31, 2024.

Check this out:
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/237671.jsp
20/11/2019 10:58 PM
kalofarmako Now that govt is removing concession, its a smart move for Pharmaniaga to focus on diversifying
22/11/2019 11:10 AM
moneytrail Lol why u guys keep posting about Pharmaniaga here. This is DPHARMA.
23/11/2019 9:57 PM
myinvestor DMSB (DPHARMA) received contract extension for 2 years (2019-2021) from Pharmaniaga Logistic S/b (PLSB).
25/11/2019 6:27 PM
kalofarmako https://klse.i3investor.com/blogs/MYpharmaceuticalnews/240245.jsp

PHARMANIAGA MAY STILL HAVE THE UPPER HAND
26/11/2019 2:42 PM
factorrumour Duopharma Biotech Berhad (“Duopharma Biotech” or the “Company”) is pleased to announce that the Government of Malaysia (“Government”) has written to Biocon Sdn. Bhd. (“Biocon”) and the Company to inform that the Government has agreed to amend the Agreement for the Supply and Delivery of Human Insulin Products (hereinafter referred to as “Agreement”) between the Government, Biocon as the manufacturer and Duopharma Marketing Sdn. Bhd. (formerly known as CCM Pharmaceuticals Sdn. Bhd.) (“DMktg”) (a wholly-owned subsidiary of the Company) as Biocon’s Authorised Distributor / Reseller. The amendments include an extension of the contract period under the Agreement by one (1) year effective from 2 December 2019 until 1 December 2020 with an additional contract value of RM91,060,000.00.
02/12/2019 10:09 PM
kalofarmako Pharmaniaga is contributing to non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) to support the registration of a new treatment for those with hepatitis C in Malaysia.

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/242914.jsp
03/12/2019 9:15 AM
Gem Seeker Wait EPF finish dispose...

Then rocket.
04/12/2019 9:42 PM
kalofarmako Good news from Pharmaniaga!!!

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/247439.jsp
13/12/2019 2:53 PM
myinvestor More good news for Dpharma. Factory expansion, increase 50% product capacity next year. Inked MOU KPJ on halal products. Export products to Asean countries. Thumb up.
https://www.theedgemarkets.com/article/duopharma-biotech-bullish-performance-outlook-next-year
19/12/2019 8:32 AM
chshzhd it's time to break..
19/12/2019 2:59 PM
here No need to support firm owned by racists.
20/12/2019 3:36 PM
kalofarmako Lets take a look!

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/2019-12-31-story-h1481975295-PHARMANIAGA_READY_TO_FACE_2020.jsp
31/12/2019 9:33 AM
t_nike2002 Risky as over half of its income depends on government contracts which subject to review and heavy impact once not renewed like pharmaniaga.. Do your research on who r the people behind the said company...whether they r in line with current gov..
07/01/2020 4:36 PM
Dakewlest Anything brewing??
07/01/2020 5:44 PM
factorrumour drug is brewing
07/01/2020 8:20 PM
Shinnzaii any outbreak uncertainties are opportunities for healthcare industry...MOH also need to strictly monitor the condition...
07/01/2020 8:29 PM
chshzhd up up ..
13/01/2020 3:49 PM
CUTLOST Tp 1.8
15/01/2020 12:51 AM
EatCoconutCanWin EPs too high but big shark is holding up
15/01/2020 7:53 AM
chshzhd may have same pe as kpj
15/01/2020 10:58 AM
probability Pharmaceutical stocks spike after China reports new coronavirus cases

https://edition.cnn.com/2020/01/19/investing/asian-market-latest/index.html
20/01/2020 10:15 PM
Jokers2020 WHO to decide whether to declare a rare global public health emergency later this week....will be good for dpharma supply medication
22/01/2020 2:28 PM
sammofee extend contract, dividend and higher profit. will fly today
14/02/2020 7:31 AM
NoHopeMedia Fly to holland
14/02/2020 9:22 AM
stingray_ea Let me show u how to catch big shark ...follow me
14/02/2020 9:53 AM